Pharmacokinetic interactions of drugs with St John's wort
- PMID: 15260917
- DOI: 10.1177/0269881104042632
Pharmacokinetic interactions of drugs with St John's wort
Abstract
There is a worldwide increasing use of herbs which are often administered in combination with therapeutic drugs, raising the potential for herb-drug interactions. St John's wort (Hypericum perforatum) is one of the most commonly used herbal antidepressants. A literature search was performed using Medline (via Pubmed), Biological Abstracts, Cochrane Library, AMED, PsycINFO and Embase (all from their inception to September 2003) to identify known drug interaction with St John's wort. The available data indicate that St John's wort is a potent inducer of CYP 3A4 and P-glycoprotein (PgP), although it may inhibit or induce other CYPs, depending on the dose, route and duration of administration. Data from human studies and case reports indicate that St John's wort decreased the blood concentrations of amitriptyline, cyclosporine, digoxin, fexofenadine, indinavir, methadone, midazolam, nevirapine, phenprocoumon, simvastatin, tacrolimus, theophylline and warfarin, whereas it did not alter the pharmacokinetics of carbamazepine, dextromethorphan, mycophenolic acid and pravastatin. St John's wort decreased the plasma concentration of the active metabolite SN-38 in cancer patients receiving irinotecan treatment. St John's wort did not alter the pharmacokinetics of tolbutamide, but increased the incidence of hypoglycaemia. Several cases have been reported that St John's wort decreased cyclosporine blood concentration leading to organ rejection. St John's wort caused breakthrough bleeding and unplanned pregnancies when used concomitantly with oral contraceptives. It also caused serotonin syndrome when coadministered with selective serotonin-reuptake inhibitors (e.g. sertaline and paroxetine). Both pharmacokinetic and pharmacodynamic components may play a role in these interactions. Because the potential interaction of St John's wort with other drugs is a major safety concern, additional systematic research on herb-drug interactions and appropriate regulation in herbal safety and efficacy is needed.
Similar articles
-
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).Psychopharmacol Bull. 2001 Winter;35(1):53-64. Psychopharmacol Bull. 2001. PMID: 12397870 Review.
-
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.Clin Pharmacol Ther. 2001 Oct;70(4):317-26. Clin Pharmacol Ther. 2001. PMID: 11673747 Clinical Trial.
-
The interaction between St John's wort and an oral contraceptive.Clin Pharmacol Ther. 2003 Dec;74(6):525-35. doi: 10.1016/j.clpt.2003.08.009. Clin Pharmacol Ther. 2003. PMID: 14663455 Clinical Trial.
-
Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.Ther Drug Monit. 2008 Apr;30(2):212-7. doi: 10.1097/FTD.0b013e31816b918f. Ther Drug Monit. 2008. PMID: 18367983 Review.
-
St John's wort and depression: slight efficacy at best, many drug interactions.Prescrire Int. 2004 Oct;13(73):187-92. Prescrire Int. 2004. PMID: 15499702
Cited by
-
Botanical and dietary supplements for menopausal symptoms: what works, what does not.J Womens Health (Larchmt). 2005 Sep;14(7):634-49. doi: 10.1089/jwh.2005.14.634. J Womens Health (Larchmt). 2005. PMID: 16181020 Free PMC article. Review.
-
Hyperforin in St. John's wort drug interactions.Eur J Clin Pharmacol. 2006 Mar;62(3):225-33. doi: 10.1007/s00228-006-0096-0. Epub 2006 Feb 14. Eur J Clin Pharmacol. 2006. PMID: 16477470 Review.
-
Integration of preclinical and clinical data with pharmacokinetic modeling and simulation to evaluate fexofenadine as a probe for hepatobiliary transport function.Pharm Res. 2009 Aug;26(8):1942-51. doi: 10.1007/s11095-009-9909-z. Epub 2009 Jun 4. Pharm Res. 2009. PMID: 19495943 Free PMC article.
-
Role of Hydroxytyrosol and Oleuropein in the Prevention of Aging and Related Disorders: Focus on Neurodegeneration, Skeletal Muscle Dysfunction and Gut Microbiota.Nutrients. 2023 Apr 4;15(7):1767. doi: 10.3390/nu15071767. Nutrients. 2023. PMID: 37049607 Free PMC article. Review.
-
Structural Perspectives of the CYP3A Family and Their Small Molecule Modulators in Drug Metabolism.Liver Res. 2019 Dec;3(3-4):132-142. doi: 10.1016/j.livres.2019.08.001. Epub 2019 Aug 29. Liver Res. 2019. PMID: 32789028 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous